The University of Minnesota is no Pfizer or Merck. But that doesn’t mean it shouldn’t act more like Big Pharma.The school has begun an ambitious effort to convert its considerable drug research into actual products. The idea is to better coordinate drug discovery projects among programs like the Masonic Cancer Center, medical school and College [...]

The new $10 million early stage venture fund jointly run by Affinity Capital Management in Minneapolis and Triathlon Medical Ventures in Cincinnati finally has a name: Northern Lights Seed Capital.From managing partner Barbara Nelsen’s LinkedIn profile:Northern Lights Seed Capital, LP is a venture capital limited partnership, headquartered in Minneapolis, Minnesota. The Fund has been established [...]